CELL AND GENE THERAPY INSIGHTS

September 2019 Issue

Volume 5 Issue 9

Cell and Gene Therapy Insights Volume 5 Issue 9
Download PDF

Featuring

Issue Spotlight: Downstream Bioprocessing Update
Supply Chain focus: Biologistics Strategy for Scale-Up
Other articles
Webinars

SPOTLIGHT

Downstream Bioprocessing Update

Michael Covington
Guest Editor:
Michael Covington, Vice President, Regulatory CMC at Orchard Therapeutics

Expert Insight

Responding to the challenges of flow cytometry in GMP product testing, a technical evaluation of the Accellix platform

Responding to the challenges of flow cytometry in GMP product testing, a technical evaluation of the Accellix platform

J Ivatury, C O’Malley, S Kunitake et al.
4 October 2019
Read
Developing a quality control program for advanced therapy medicinal products in Europe

Developing a quality control program for advanced therapy medicinal products in Europe

Margarita Codinach
2 October 2019
Read
Vector purification: issues and challenges with currently available technologies

Vector purification: issues and challenges with currently available technologies

David Moss
19 September 2019
Read

Innovator Insight

Optimizing the clarification of industrial scale viral vector culture for gene therapy

Optimizing the clarification of industrial scale viral vector culture for gene therapy

B Raghavan, M Collins, S Walls et al.
13 January 2019
Read

Interview

Innovation and issues in hPS cell bioprocessing

Innovation and issues in hPS cell bioprocessing

Chuck Murry
19 September 2019
Read

Regulatory Insight

Sterility sampling of cell and gene therapy products

Sterility sampling of cell and gene therapy products

Timothy Wood
16 October 2019
Read

Supply Chain FOCUS

Biologistics Strategy for Scale-Up

Innovator Insight

Process development considerations for cryopreservation of cellular therapies

Process development considerations for cryopreservation of cellular therapies

Alireza Abazari
11 November 2019
Read

Interview

Mitigating raw materials risk during preclinical-clinical transitioning

Mitigating raw materials risk during preclinical-clinical transitioning

Adam Hostetler, Gerry Maybach
9 December 2019
Read
Mitigating risk in the gene therapy supply chain

Mitigating risk in the gene therapy supply chain

Chad Presher
4 November 2019
Read
Preparing a patient-specific cellular immunotherapy supply chain for commercialisation

Preparing a patient-specific cellular immunotherapy supply chain for commercialisation

Dirk De Naeyer
3 November 2019
Read

Expert Roundtable Video

Expert Roundtable: Critical needs & challenges for the cell & gene therapy raw materials supply chain

Expert Roundtable: Critical needs & challenges for the cell & gene therapy raw materials supply chain

S Baila, M Frechette, D Goel et al.
11 November 2019
Watch

Expert Roundtable

Critical needs and challenges for the cell and gene therapy raw materials supply chain

Critical needs and challenges for the cell and gene therapy raw materials supply chain

S Baila, M Frechette, K Francis et al.
25 November 2019
Read

Journal articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – August 2019

Cell & Gene Therapy Commercial Insight – August 2019

Mark Curtis, Richard Philipson
9 October 2019
Read

Webinars